You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
The puzzle of AIDS diagnoses before the 1985 test
Between 1979 and 1985 AIDS was diagnosed without an HIV test. The paradox between nonspecific symptoms and test validation fuels a debate with no settled answer.
Between 1979 and March 1985 there was no laboratory test for HIV. And yet the media reported cases, hospitals counted deaths and the authorities spoke of an epidemic. The paradox, pointed out insistently in a debate that has gone on for years, is this: if today's medical literature repeats that HIV infection can only be established through a specific test and that clinical manifestations are nonspecific at every stage, how were the first AIDS cases diagnosed before that test existed?
The first documented case dates to June 5, 1981 in the United States, and in Spain to October of that same year at Vall d'Hebron Hospital. The first test approved by the FDA arrived on March 2, 1985. In between, four years of diagnoses with no diagnostic tool. Some articles from the era, recovered from newspaper archives, push the starting point back even further, to 1979.
The contradiction nobody closes
The central objection is logical, not medical. If symptoms cannot be used to diagnose the infection, the test is indispensable. But if the test was validated by comparing it with patients already clinically diagnosed with AIDS, then symptoms did work. The circle bites its own tail: either the test is superfluous, or it is useless because its validation reference is the very thing it claims cannot be used.
Some respond that medicine advances by accumulation and that diseases are described before they are understood. The classic example: nobody knew what caused hepatitis, yet the clinical picture was already being distinguished. One doctor taking part in the conversation puts it this way: a group of people appears with symptoms that fit nothing described so far, and the cause is sought. It is a reasonable argument, though it sidesteps the exact point: describing a syndrome is one thing, asserting that a specific bicho lies behind it is another.
What the test insert says
The other front in the debate is the test itself. It is argued that the inserts admit the presence of the bicho is assumed in those who test positive, and that there is no independent gold standard confirming that presence. The orthodox defense concedes part of the ground: it is acknowledged that there is no gold standard and that the Western Blot operates with estimated error rates. The discussion then shifts to viral load and lymphocyte counts as parameters for starting treatment.
The jump to Ebola completes the picture. If diagnosis today requires a specific test, how was the 1976 outbreak identified without one? The same structure of question, applied to another pathogen, serves to question the entire method.
The case that upends the timeline
The newspaper archives supply the most uncomfortable data point: deaths attributed to AIDS in 1983, when the test would not arrive until two years later. The most common answer is that retrospective attribution is common practice in epidemiology. That may be true. It is also true that it turns diagnosis into a later reconstruction, not a medical act of the moment.
How many of the cases counted in those years would today withstand the very criterion orthodoxy itself demands?
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication.
Read the full discussion (79 replies).
Wali, the Canadian sniper who went to fight in Ukraine, returns home after firing only two shots and admits his disappointment with the international legion.
Ukrainian soldier Kostiantyn Vlasenko survived 491 days alone in a concrete pipe, amputated his own foot with a knife and was evacuated by drone from the front line.
Forum debate: faced with a hypothetical European draft, several users argue that young people would not go to the front due to lack of prospects and miserable wages.
Bloomberg reports that China is negotiating the purchase of Gazprom and Rusal through its state-owned companies while Europe looks for more expensive gas in other markets.